The forecast for anaemia prevalence among pregnant women in the US indicates a consistent upward trend from 2024-2028, with values increasing from 17.7% in 2024 to 18.42% in 2028. Compared to the actual value in 2023, this signifies a gradual rise. Year-on-year percentage variations show a steady escalation, highlighting a concerning trend of increasing anaemia prevalence in the given population. Over the five-year period, the CAGR reflects sustained growth, implying persistent challenges in managing anaemia among pregnant women.

Future trends to watch for include:

Impact of healthcare interventions and nutritional programs on anaemia reduction.
Socioeconomic factors affecting access to healthcare and nutrition for pregnant women.
Advancements in medical research and technology potentially offering new treatments.
Policy changes influencing maternal health care and nutritional support.